Jin Yang Pharmaceutical Co., Ltd. (007370.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩3,495 (-0.71%) as of
Key statistics
- Market cap
- 49.40B
- Dividend yield
- 4.26%
- 52-week range
- 3,315.00 – 5,700.00
- Beta
- 0.37
- Revenue (TTM)
- 124.61B
- Profit margin
- 18.30%
- Volume
- 77.66k
About Jin Yang Pharmaceutical Co., Ltd.
Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.